)
Gourab Chatterjee
Gourab leads strategy and management across Ultivue’s Product, Services, and Image Analysis portfolios. Over the last eight years, he and his team have made groundbreaking advances combining InSituPlex® and STARVUE™, to support translational and clinical researchers with integrated solutions that provide pathology-grade high-fidelity biological insights to validate their clinical trial hypotheses. He also led R&D efforts developing Ultivue’s foundational InSituPlex® (ISP) assays and expanded its applications through OmniVUE™ and U-VUE® biomarker panels for immuno-oncology and Antibody-drug conjugate (ADC) therapies. Gourab holds a Ph.D. in Bioengineering from the University of Washington Seattle, where he developed novel DNA-based nanosystems capable of molecular computation inside living cells.